{
    "eid": "2-s2.0-85105599444",
    "title": "Translational evidence for the Inflammatory Response System (IRS)/Compensatory Immune Response System (CIRS) and neuroprogression theory of major depression",
    "cover-date": "2021-12-20",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Biological Psychiatry",
            "@code": "2803",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "Depression",
        "Immune regulatory",
        "Immune system",
        "Inflammation",
        "Major depressive disorder",
        "Mood disorders",
        "Neuroprogression",
        "Neuroscience",
        "Psychiatry"
    ],
    "authors": [
        "Monojit Debnath",
        "Michael Berk",
        "Michael Maes"
    ],
    "citedby-count": 19,
    "ref-count": 113,
    "ref-list": [
        "Altered B cell homeostasis in patients with major depressive disorder and normalization of CD5 surface expression on regulatory B cells in treatment responders",
        "Abnormal distribution and function of circulating monocytes and enhanced bacterial translocation in major depressive disorder",
        "Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications",
        "Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression",
        "Suicide risk in patients with major depressive disorder",
        "B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas",
        "The activation status of human macrophages presenting antigen determines the efficiency of Th17 responses",
        "Immune mechanisms linked to depression via oxidative stress and neuroprogression",
        "Interferon-gamma increases neuronal death in response to amyloid-beta1-42",
        "Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study",
        "Acute phase proteins in major depression",
        "So depression is an inflammatory disease, but where does the inflammation come from?",
        "Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trial",
        "Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods",
        "Inflammatory T helper 17 cells promote depression-like behavior in mice",
        "Systemic inflammation is associated with depressive symptoms differentially by sex and race: a longitudinal study of urban adults",
        "Inhibitory role for GABA in autoimmune inflammation",
        "Pro- and anti-inflammatory properties of interleukin (IL6) in vitro: relevance for major depression and for human hippocampal neurogenesis",
        "Single-cell mass cytometry of microglia in major depressive disorder reveals a non-inflammatory phenotype with increased homeostatic marker expression",
        "Hippocampal volume reduction in major depression",
        "Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation",
        "Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation",
        "Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: a randomized, double-blind control study",
        "Macrophage activation: classical versus alternative",
        "Elevated IL-17 and TGF-beta serum levels: a positive correlation between T-helper 17 cell-related pro-inflammatory responses with major depressive disorder",
        "Cytokine-neurotransmitter interactions in the brain",
        "Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys",
        "Insights into macrophage heterogeneity and cytokine-induced neuroinflammation in major depressive disorder",
        "A meta-analysis of cytokines in major depression",
        "Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue",
        "Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise",
        "Circulating T helper 17 and IFN-gamma positive Th17 cells in Major Depressive Disorder",
        "Origin, fate and dynamics of macrophages at central nervous system interfaces",
        "Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression",
        "Deficiencies of the T and natural killer cell system in major depressive disorder: T regulatory cell defects are associated with inflammatory monocyte activation",
        "Innate and adaptive immunity in the development of depression: an update on current knowledge and technological advances",
        "The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis",
        "Imbalance between Th17 and Treg cells may play an important role in the development of chronic unpredictable mild stress-induced depression in mice",
        "Relationship between interleukin (IL)-6 and brain morphology in drug-naive, first-episode major depressive disorder using surface-based morphometry",
        "Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder",
        "A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder",
        "Cytokine imbalance in the pathophysiology of major depressive disorder",
        "The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill",
        "Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials",
        "Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials",
        "Stimulatory effect of antidepressants on the production of IL-6",
        "Serum chemokine levels in major depressive disorder",
        "Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats",
        "The concept of depression as a dysfunction of the immune system",
        "Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder",
        "Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis",
        "A review on the acute phase response in major depression",
        "The Compensatory Immune-Regulatory Reflex System (CIRS) in depression and bipolar disorder",
        "Immune disturbances during major depression: upregulated expression of interleukin-2 receptors",
        "Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining",
        "Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness",
        "Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression",
        "The monocyte-T-lymphocyte hypothesis of major depression",
        "Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression",
        "Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion",
        "Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression",
        "Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?",
        "The chemokine system in diverse forms of macrophage activation and polarization",
        "IL-10 modulates depressive-like behavior",
        "Neuroprogression and immune activation in major depressive disorder",
        "Depression and immunity: a role for T cells?",
        "M1 and M2 macrophages: the chicken and the egg of immunity",
        "M-1/M-2 macrophages and the Th1/Th2 paradigm",
        "Interleukin-10 and the interleukin-10 receptor",
        "The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications",
        "The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression",
        "Macrophage polarization",
        "Macrophage activation and polarization: nomenclature and experimental guidelines",
        "Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR",
        "Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls",
        "Inflammatory and innate immune markers of neuroprogression in depressed and teenage suicide brain",
        "Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims",
        "Innate immunity in the postmortem brain of depressed and suicide subjects: role of Toll-like receptors",
        "T cell phenotype and T cell receptor repertoire in patients with major depressive disorder",
        "Muscle as an endocrine organ: focus on muscle-derived interleukin-6",
        "T cell subsets and their signature cytokines in autoimmune and inflammatory diseases",
        "Immunological differences between patients with major depression and somatization syndrome",
        "Expanded regulatory T cells induce alternatively activated monocytes with a reduced capacity to expand T Helper-17 cells",
        "Depression and suicidality: a link to premature T helper cell aging and increased Th17 cells",
        "Subcortical brain alterations in major depressive disorder: findings from the ENIGMA major depressive disorder working group",
        "Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-beta",
        "The role of serotonin and its receptors in activation of immune responses and inflammation",
        "The macrophage theory of depression",
        "Cytokines mediated inflammation and decreased neurogenesis in animal models of depression",
        "Lipid peroxidation and immune biomarkers are associated with major depression and its phenotypes, including treatment-resistant depression and melancholia",
        "Hypothermia increases interleukin-6 and interleukin-10 in juvenile endotoxemic mice",
        "Relationship between white matter integrity and serum inflammatory cytokine levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics",
        "Altered populations of natural killer cells, cytotoxic T lymphocytes, and regulatory T cells in major depressive disorder: association with sleep disturbance",
        "Defective inflammatory pathways in never-treated depressed patients are associated with poor treatment response",
        "CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages",
        "Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides",
        "Hippocampal volume and depression: a meta-analysis of MRI studies",
        "Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors",
        "Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease?",
        "Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats",
        "Plasma complement component 4 increases in patients with major depressive disorder",
        "Effect of antidepressant treatment on peripheral inflammation markers \u2013 a meta-analysis",
        "Effects of immunomodulatory drugs on depressive symptoms: a mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders",
        "Interleukin-6 contributes to early fasting-induced free fatty acid mobilization in mice",
        "IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses",
        "Ketamine exerts antidepressant effects and reduces IL-1beta and IL-6 levels in rat prefrontal cortex and hippocampus",
        "Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression",
        "Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression",
        "Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder",
        "Effects of tumor necrosis factor-alpha polymorphism on the brain structural changes of the patients with major depressive disorder",
        "Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety",
        "TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition",
        "Changes in the serum levels of inflammatory cytokines in antidepressant drug-naive patients with major depression"
    ],
    "affiliation": [
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60026553",
            "affilname": "University of Melbourne",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026553",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bengaluru",
            "@id": "60016175",
            "affilname": "National Institute of Mental Health and Neuro Sciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016175",
            "affiliation-country": "India"
        }
    ],
    "funding": [
        "Cooperative Research Centre",
        "Harry Windsor Foundation",
        "Lundbeck Merck",
        "Meat and Livestock Board",
        "Medical Research Futures Fund",
        "Simons Autism Foundation",
        "Stanley Medical Research Foundation",
        "NIH",
        "Pfizer",
        "National Health and Medical Research Council",
        "Cancer Council of Victoria",
        "Servier"
    ]
}